Overview

Study of REGN1500 in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

Status:
Completed
Trial end date:
2018-07-23
Target enrollment:
Participant gender:
Summary
This is an open-label, single-arm study to assess the reduction of low-density lipoprotein cholesterol (LDL-C) by REGN1500 in patients with homozygous familial hypercholesterolemia (HoFH).
Phase:
Phase 2
Details
Lead Sponsor:
Regeneron Pharmaceuticals